Drug intelligence / Profile preview

dexamethasone + dipyrone + hydroxocobalamin

Development stage
Unknown
Lead developer
Merck
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
Administration
Intramuscular
01

Overview

**Dexamethasone + dipyrone + hydroxocobalamin** is an injectable combination drug used primarily for the management of acute and chronic inflammatory and pain conditions, such as lumbar sciatic pain and acute joint inflammation. Dexamethasone is a synthetic glucocorticoid with potent anti-inflammatory and immunosuppressive effects, acting through glucocorticoid receptors to modulate gene expression and inflammatory mediator production. Dipyrone (also known as metamizole) is a non-opioid analgesic and antipyretic agent of the pyrazolone class, providing pain relief and reduction of fever through inhibition of prostaglandin synthesis, likely via cyclooxygenase enzymes. Hydroxocobalamin is a biologically active form of vitamin B12 with essential roles in cellular metabolism and neuroprotection, and it may further contribute to neural repair in nerve injury. The combination is under investigation in parenteral formulations for enhanced efficacy in acute inflammatory pain syndromes, particularly where rapid and multimodal analgesia is required[1][4].

Brand names
Dexalgen
Other names
metamizole + dexamethasone + hydroxocobalamin
02

Targets

GR (Glucocorticoid receptor)COX-3 (Mitochondrially encoded cytochrome c oxidase subunit 3)MR (Mineralocorticoid receptor)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)PGHS-1 (Prostaglandin G/H Synthase 1)

Beyond the preview

Go deeper on dexamethasone + dipyrone + hydroxocobalamin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on dexamethasone + dipyrone + hydroxocobalamin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call